Lead, In Vivo Gene Editing Hemoglobinopathies
Listed on 2026-10-08
-
Research/Development
Research Scientist, Pharmaceutical Science/ Research
Scorpion Therapeutics seeks a senior leader to drive lead discovery and translational research for in vivo gene editing therapies targeting hemoglobinopathies. The role spans target selection, preclinical work, IND-enabling studies, and Phase 1/2 trial readiness.
Responsibilities include shaping scientific strategy, guiding in vitro/ex vivo/in vivo studies, supporting candidate optimization, and leading cross-functional teams toward nomination of a development candidate.
As a Lead, In Vivo Gene Editing for Hemoglobinopathies, you will play an important part at Scorpion Therapeutics in Boston, MA, United States.
Consider building your career as a Lead, In Vivo Gene Editing for Hemoglobinopathies at Scorpion Therapeutics.
The Lead, In Vivo Gene Editing for Hemoglobinopathies position in the Bio & Pharmacology & Health field is open for applications.
We have an opening for a Lead, In Vivo Gene Editing for Hemoglobinopathies in Boston, MA, United States within Bio & Pharmacology & Health.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).